- Home
- YXT vs ANIX Comparison
YXT vs ANIX Comparison
Compare YXT & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YXT
- ANIX
- Stock Information
- Founded
- YXT 2011
- ANIX 1982
- Country
- YXT China
- ANIX United States
- Employees
- YXT N/A
- ANIX N/A
- Industry
- YXT
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- YXT
- ANIX Health Care
- Exchange
- YXT NYSE
- ANIX Nasdaq
- Market Cap
- YXT 102.1M
- ANIX 84.7M
- IPO Year
- YXT 2024
- ANIX 1987
- Fundamental
- Price
- YXT $0.66
- ANIX $2.75
- Analyst Decision
- YXT
- ANIX Strong Buy
- Analyst Count
- YXT 0
- ANIX 3
- Target Price
- YXT N/A
- ANIX $9.00
- AVG Volume (30 Days)
- YXT 33.6K
- ANIX 54.9K
- Earning Date
- YXT 05-21-2025
- ANIX 06-03-2025
- Dividend Yield
- YXT N/A
- ANIX N/A
- EPS Growth
- YXT N/A
- ANIX N/A
- EPS
- YXT N/A
- ANIX N/A
- Revenue
- YXT $45,374,087.00
- ANIX N/A
- Revenue This Year
- YXT N/A
- ANIX N/A
- Revenue Next Year
- YXT N/A
- ANIX N/A
- P/E Ratio
- YXT $1.24
- ANIX N/A
- Revenue Growth
- YXT N/A
- ANIX N/A
- 52 Week Low
- YXT $0.69
- ANIX $2.07
- 52 Week High
- YXT $11.00
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- YXT N/A
- ANIX 50.69
- Support Level
- YXT N/A
- ANIX $2.60
- Resistance Level
- YXT N/A
- ANIX $2.88
- Average True Range (ATR)
- YXT 0.00
- ANIX 0.20
- MACD
- YXT 0.00
- ANIX 0.02
- Stochastic Oscillator
- YXT 0.00
- ANIX 83.64
About YXT YXT.COM GROUP HOLDING LIMITED SPON ADS EA REP 3 CL A SHS
Yxt.Com Group Holding Ltd operates as a technology company. The company has created a SaaS model that integrates software and content, assisting customers in the digital transformation of corporate learning. The company operates in the People's Republic of China.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.